Literature DB >> 31407058

Subarachnoid Hemorrhage-Related Epilepsy.

Warren Boling1, Lydia Kore2.   

Abstract

Epilepsy is a significant worldwide public health problem that leads to reduced quality of life and negative psychosocial consequences and significantly increases mortality rates in those who are affected. The development of epilepsy from subarachnoid hemorrhage (SAH) has an important negative impact on long-term survival, functional status, and cognitive recovery in patients following aneurysmal rupture. Anticonvulsant medication (AED) administration to prevent the development of epilepsy following SAH is controversial, and studies to date have not shown effectiveness of AED use as prophylaxis. This paper reviews the pathophysiology of SAH in the development of epilepsy, the scope of the problem of epilepsy related to SAH, and the studies that have evaluated AED administration as prophylaxis for seizures and epilepsy.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31407058     DOI: 10.1007/978-3-030-04615-6_4

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  2 in total

Review 1.  Emerging Role of Microglia-Mediated Neuroinflammation in Epilepsy after Subarachnoid Hemorrhage.

Authors:  Jingxue Liang; Jiahong Deng; Xiaolin Liang; Jun Wang; Kewan Wang; Hongxiao Wang; Dadi Qian; Hao Long; Kaijun Yang; Songtao Qi
Journal:  Mol Neurobiol       Date:  2021-01-26       Impact factor: 5.590

2.  Pharmaceutical Management for Subarachnoid Hemorrhage.

Authors:  Arnav Barpujari; Chhaya Patel; Rebecca Zelmonovich; Alec Clark; Devan Patel; Kevin Pierre; Kyle Scott; Brandon Lucke Wold
Journal:  Recent Trends Pharm Sci Res       Date:  2021
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.